Products - Heart failure | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 41 products

Date | Title

Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (DG61)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
24 October 2024
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA929)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
1 November 2023
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA902)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
21 June 2023
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal) (TA790)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 May 2022
Empagliflozin for treating chronic heart failure with reduced ejection fraction (TA773)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
9 March 2022
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure (IPG711)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 November 2021
Acute heart failure: diagnosis and management (CG187)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
17 November 2021
Published:
8 October 2014
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal) (TA731)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
29 September 2021
Permanent His-bundle pacemaker implantation for treating heart failure (IPG694)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
5 May 2021
Dapagliflozin for treating chronic heart failure with reduced ejection fraction (TA679)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
24 February 2021
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease (IPG677)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
5 August 2020
Cardiac contractility modulation device implantation for heart failure (IPG655)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 June 2019
Chronic heart failure in adults: diagnosis and management (NG106)
Product type:
Guidance
Programme:
NICE guideline
Published:
12 September 2018
Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure (IPG602)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
20 December 2017
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (TA388)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 April 2016
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation (IPG516)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 March 2015
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (TA314)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 June 2014
Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 March 2014
Ivabradine for treating chronic heart failure (TA267)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
28 November 2012
Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery (IPG177)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
28 June 2006
Partial left ventriculectomy (the Batista procedure) (IPG41)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 February 2004
The OPTIMIZER smart system for managing heart failure (MIB186)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
27 June 2019
Remote ECG interpretation consultancy services for cardiovascular disease (MIB152)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
27 July 2018
CentriMag for heart failure (MIB92)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
18 January 2017
The AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation (MIB18)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
12 February 2015
Chronic heart failure in adults (QS9)
Product type:
Quality standard
Last updated:
10 January 2023
Published:
29 June 2011
Acute heart failure (QS103)
Product type:
Quality standard
Published:
3 December 2015
Chronic heart failure in adults: diagnosis and management - Pharmacological treatment of chronic heart failure
Status:
In development
Programme:
NICE guideline
Expected publication date:
13 August 2025
Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adults
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
11 September 2025
⁠Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for postcardiotomy cardiogenic shock in adults
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
11 September 2025
Digital platforms to support cardiac rehabilitation: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
18 November 2025
Pulmonary artery pressure technologies for remote monitoring of chronic heart failure
Status:
In development
Programme:
Diagnostics guidance
Expected publication date:
20 January 2026
Insertion of a Catheter based intravascular microaxial blood pump for acute heart failure
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
11 March 2026
Implantable Vagus Nerve Stimulator in Heart Failure
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Rivaroxaban for treating chronic heart failure [ID1462]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction [ID3912]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sacubitril valsartan for treating chronic heart failure with reduced ejection fraction in people under 18 years [TSID10350]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for treating obesity-related heart failure with preserved ejection fraction [TSID11788]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
An aortic cuff counterpulsation system for the treatment of heart failure
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction [ID6514]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC